What was corrected and how
A subsequent correction by the company to the contents of an already published filing.
Notice Regarding the Full Subsidiarization of 株式会社IMGホールディングス through a Share Exchange
In 4. Overview of the Parties to This Share Exchange: (11) Major Shareholders and Ownership Ratios; (12) Related-Party Status in the Relationship between the Parties; and (13) Presentation Classification of Consolidated Performance and Consolidated Financial Position for the Most Recent 3 Years
株式会社Medical Management Consulting (Representative Director: Yasui Hirotomo (安井 浩倫)) 91.00%, Yasui Hirotomo (安井 浩倫) 6.00%, Utsunomiya Yuki (宇都宮 由生) 2.00%, Sugiyama Ryota (杉山 亮太) 1.00%
As of 1 August 2025 株式会社スマイル・オン 16.10%, 株式会社トライユニティ 16.10%, Tasaka Daisaku (田坂大作) 13.00%, Imamura Go (今村豪) 13.00%, Imamura Kai (今村海) 11.90%, Yasui Hirotomo (安井浩倫) 6.00%, Tasaka Nao (田坂菜央) 4.70%, Tasaka Kota (田坂凰太) 4.70%, 有限会社オーティーエヌ 4.50%, Tasaka Masaki (田坂将貴) 2.00%, Imamura Riku (今村陸) 2.00%, Imamura Kai (今村海) 2.00%, Utsunomiya Yuki (宇都宮由生) 2.00%, Sugiyama Ryota (杉山亮太) 1.00%, Ono Yohei (小野洋平) 1.00% / As of 28 November 2025 株式会社Medical Management Consulting 24.44%, 株式会社スマイル・オン 15.13%, 株式会社トライユニティ 15.13%, Yasui Hirotomo (安井浩倫) 8.27%, 有限会社オーティーエヌ 4.23%, Utsunomiya Yuki (宇都宮由生) 1.88%, Sugiyama Ryota (杉山亮太) 0.94%, 34 other individuals 29.98%
The independent investigation committee's final investigation report revealed that only the temporary shareholder composition had been disclosed.
| Item | Details |
|---|---|
| Disclosure subject to correction | Notice Regarding the Full Subsidiarization of 株式会社IMGホールディングス through a Share Exchange |
| Original disclosure date | 14 October 2025 |
| Location of correction | In 4. Overview of the Parties to This Share Exchange: (11) Major Shareholders and Ownership Ratios; (12) Related-Party Status in the Relationship between the Parties; and (13) Presentation Classification of Consolidated Performance and Consolidated Financial Position for the Most Recent 3 Years |
| Details of correction | 株式会社Medical Management Consulting (Representative Director: Yasui Hirotomo (安井 浩倫)) 91.00%, Yasui Hirotomo (安井 浩倫) 6.00%, Utsunomiya Yuki (宇都宮 由生) 2.00%, Sugiyama Ryota (杉山 亮太) 1.00% → As of 1 August 2025 株式会社スマイル・オン 16.10%, 株式会社トライユニティ 16.10%, Tasaka Daisaku (田坂大作) 13.00%, Imamura Go (今村豪) 13.00%, Imamura Kai (今村海) 11.90%, Yasui Hirotomo (安井浩倫) 6.00%, Tasaka Nao (田坂菜央) 4.70%, Tasaka Kota (田坂凰太) 4.70%, 有限会社オーティーエヌ 4.50%, Tasaka Masaki (田坂将貴) 2.00%, Imamura Riku (今村陸) 2.00%, Imamura Kai (今村海) 2.00%, Utsunomiya Yuki (宇都宮由生) 2.00%, Sugiyama Ryota (杉山亮太) 1.00%, Ono Yohei (小野洋平) 1.00% / As of 28 November 2025 株式会社Medical Management Consulting 24.44%, 株式会社スマイル・オン 15.13%, 株式会社トライユニティ 15.13%, Yasui Hirotomo (安井浩倫) 8.27%, 有限会社オーティーエヌ 4.23%, Utsunomiya Yuki (宇都宮由生) 1.88%, Sugiyama Ryota (杉山亮太) 0.94%, 34 other individuals 29.98% |
| Reason for correction | The independent investigation committee's final investigation report revealed that only the temporary shareholder composition had been disclosed. |
Items this document does not state (1)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The independent investigation committee's final investigation report revealed that a temporary transfer of shares in IMGホールディングス had been carried out and that, although the shareholder composition was scheduled to be restored to its previous composition before the share exchange, only the temporary shareholder composition had been disclosed.